论文信息 - Benefit‐Risk Summary of Regorafenib for the Treatment of Patients with Advanced Hepatocellular Carcinoma That Has Progressed on Sorafenib - 字舞流文

Benefit‐Risk Summary of Regorafenib for the Treatment of Patients with Advanced Hepatocellular Carcinoma That Has Progressed on Sorafenib

Jiang Liu | K. Goldberg | P. Keegan | Amy McKee | R. Pazdur | Lorraine C Pelosof | S. Lemery | Anuj K. Patel | Y. Bi | Lisa Rodriguez | S. Casak | Xiaoping Jiang | J. F. Zirkelbach | Lorraine C. Pelosof | V. Pierre | Kirsten B. Goldberg | Lisa R Rodriguez